Literature DB >> 26543650

A Rare Case of Complete Stent Fracture, Coronary Arterial Transection, and Pseudoaneurysm Formation Induced by Repeated Stenting.

Fumiaki Nakao1, Masashi Kanemoto1, Jutaro Yamada2, Kazuhiro Suzuki3, Hidetoshi Tsuboi3, Takashi Fujii1.   

Abstract

This report describes a rare asymptomatic case of complete stent fracture, coronary arterial transection, and pseudoaneurysm formation in response to repeated stenting. The proximal and distal ends of transected coronary artery were closed, and distal bypass was performed. Coronary arterial transection can occur in patients with repeated stenting as a long-term adverse event.

Entities:  

Year:  2015        PMID: 26543650      PMCID: PMC4620260          DOI: 10.1155/2015/192853

Source DB:  PubMed          Journal:  Case Rep Cardiol        ISSN: 2090-6404


1. Introduction

Stent fracture after drug-eluting stent (DES) deployment is an important issue, because it is strongly associated with restenosis, target legion revascularization, and stent thrombosis [1]. A report of autopsy cases with DES deployment showed stent fracture in 29% of lesions and restenosis or stent thrombosis in 67% of cases with gapped stent fracture [2]. Stent fracture can also lead to coronary pseudoaneurysm formation, which can be life-threatening [3]. The incidence of coronary pseudoaneurysm formation after DES deployment is 0.3–4.5% [4]. Management strategies for coronary pseudoaneurysm include observation, surgical treatment and interventional treatment, such as coil embolization and deployment of a polytetrafluoroethylene- (PTFE-) covered stent [3-5].

2. Case Report

A 61-year-old male undergoing chronic hemodialysis had previously underwent rotational atherectomy and stenting (TAXUS Liberte, Boston Scientific Co.) for a long, severely calcified lesion of the right coronary artery (RCA) (first percutaneous coronary intervention [PCI#1], Figure 1). Six months later, the patient underwent emergent restenting (Cypher, Cordis) for probable stent thrombosis of the mid-RCA with ST elevation (second PCI [PCI#2], Figure 2). Four months later, he underwent emergent repeat stenting (Xience V, Abbott Vascular) for probable stent thrombosis of the mid-RCA with ST elevation (third PCI [PCI#3], Figure 3). Two months later, he was admitted for follow-up coronary angiography (CAG) and was noted to be asymptomatic. CAG showed pseudoaneurysm formation in the mid-RCA (see Figures 4(a), 4(b), and 4(c) and see Clip  1 in Supplementary Material available online at http://dx.doi.org/10.1155/2015/192853), and X-ray fluorography showed complete stent fracture (Figure 4(d)). Coronary transection was suspected, because of findings of complete stent fracture and contrast media oozing all around the part of stent fracture.
Figure 1

First percutaneous coronary intervention (PCI#1). (a) Baseline coronary angiography (CAG). (b) CAG after first stenting.

Figure 2

Second percutaneous coronary intervention (PCI#2). (a) Baseline coronary angiography (CAG). (b) CAG after second stenting.

Figure 3

Third percutaneous coronary intervention (PCI#3). (a) Baseline coronary angiography (CAG). (b) CAG after third stenting.

Figure 4

Follow-up coronary angiography showing pseudoaneurysm formation. Left anterior oblique (LAO) view (a), right anterior oblique view (b), and LAO-cranial view (c). (d) X-ray fluorography showing complete stent fracture.

3. Discussion

Risk factors for stent fracture include RCA stenting, long stenting, overlapped stenting, and stenting on a hinge point [6, 7]. The present patient underwent long and overlapped stenting within the RCA and therefore was at high risk for stent fracture. Drugs and polymers of DES may induce vascular inflammation and delay vascular healing [8], and they also can contribute to pseudoaneurysm formation. In this case, the vessel wall was likely exposed to a relatively high dose of DES drug and polymer (due to three overlapping stents). Surgical treatment and a PTFE-covered stent deployment were considered for this case. However, a guidewire could perforate the wall of the pseudoaneurysm, and deployment of the PTFE-covered stent might be difficult, because previous procedures required the mother and child (4 in 6) technique. If repeated stenting for stent fracture was performed, stent fracture might occur repeatedly, leading to lethal stent thrombosis or blow-out rupture of the pseudoaneurysm. Therefore, surgical management was selected for this case. During surgery, the pseudoaneurysm was visualized in the visceral adipose tissue (arrow heads, Figure 5(a)). After the pseudoaneurysm was opened (Figure 5(b)), coronary transection was confirmed (arrows, Figure 5(b)). The proximal and distal transected ends of the mid-RCA could not be ligated because of protrusion of the overlapped fractured struts (arrows, Figure 5(c)). Therefore, proximal and distal transected ends of the mid-RCA were closed (Figure 5(d)), and distal bypass was performed.
Figure 5

Intraoperative findings. The pseudoaneurysm is in the visceral adipose tissue (arrow heads) (a) and opened (b). (c) Coronary arterial transection. (d) Proximal and distal transected ends are closed.

In conclusion, this case report described a rare asymptomatic case of complete stent fracture, coronary arterial transection, and pseudoaneurysm formation in response to repeated stenting. Coronary arterial transection can occur in patients with repeated stenting as a long-term adverse event. Follow-up coronary angiography of right coronary artery shows pseudoaneurysm formation and complete stent fracture. Coronary transection is suspected, because of findings of complete stent fracture and contrast media oozing all around the part of stent fracture.
  8 in total

1.  Incidence and clinical impact of stent fracture after everolimus-eluting stent implantation.

Authors:  Shoichi Kuramitsu; Masashi Iwabuchi; Takuya Haraguchi; Takenori Domei; Ayumu Nagae; Makoto Hyodo; Kyohei Yamaji; Yoshimitsu Soga; Takeshi Arita; Shinichi Shirai; Katsuhiro Kondo; Kenji Ando; Koyu Sakai; Masahiko Goya; Yoshitaka Takabatake; Shinjo Sonoda; Hiroyoshi Yokoi; Fumitoshi Toyota; Hideyuki Nosaka; Masakiyo Nobuyoshi
Journal:  Circ Cardiovasc Interv       Date:  2012-09-25       Impact factor: 6.546

2.  A case of coronary rupture and pseudoaneurysm formation after fracture of implanted paclitaxel-eluting stents.

Authors:  Yasuyuki Kawai; Michihiko Kitayama; Hironobu Akao; Atsushi Motoyama; Taketsugu Tsuchiya; Kouji Kajinami
Journal:  Cardiovasc Interv Ther       Date:  2015-05-22

3.  Stent-assisted detachable coil embolization of pseudoaneurysms in the coronary circulation.

Authors:  Anjli Maroo; Peter A Rasmussen; Thomas J Masaryk; Stephen G Ellis; A Michael Lincoff; Samir Kapadia
Journal:  Catheter Cardiovasc Interv       Date:  2006-09       Impact factor: 2.692

4.  Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans.

Authors:  Renu Virmani; Francesco Liistro; Goran Stankovic; Carlo Di Mario; Matteo Montorfano; Andrew Farb; Frank D Kolodgie; Antonio Colombo
Journal:  Circulation       Date:  2002-11-19       Impact factor: 29.690

Review 5.  Covered-stent treatment of coronary aneurysm after drug-eluting stent placement: case report and literature review.

Authors:  Sharad Bajaj; Rupen Parikh; Aiman Hamdan; Mahesh Bikkina
Journal:  Tex Heart Inst J       Date:  2010

6.  Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis.

Authors:  Gaku Nakazawa; Aloke V Finn; Marc Vorpahl; Elena Ladich; Robert Kutys; Isidora Balazs; Frank D Kolodgie; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2009-11-17       Impact factor: 24.094

7.  Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture.

Authors:  Hiroshi Doi; Akiko Maehara; Gary S Mintz; Kenichi Tsujita; Takashi Kubo; Celia Castellanos; Jian Liu; Junqing Yang; Carlos Oviedo; Jiro Aoki; Theresa Franklin-Bond; Neil Dasgupta; Alexandra J Lansky; George D Dangas; Gregg W Stone; Jeffrey W Moses; Roxana Mehran; Martin B Leon
Journal:  Am J Cardiol       Date:  2009-03-15       Impact factor: 2.778

8.  Clinical outcomes and optimal treatment for stent fracture after drug-eluting stent implantation.

Authors:  Shin Eun Lee; Myung Ho Jeong; In Soo Kim; Jum Suk Ko; Min Goo Lee; Won Yu Kang; Soo Hyun Kim; Doo Sun Sim; Keun Ho Park; Nam Sik Yoon; Hyun Ju Yoon; Kye Hun Kim; Young Joon Hong; Hyung Wook Park; Ju Han Kim; Young Keun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  J Cardiol       Date:  2009-03-21       Impact factor: 3.159

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.